| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 5 | |
| #2 | WIPO (World Intellectual Property Organization) | 5 | |
| #3 | Canada | 4 | |
| #4 | China | 1 | |
| #5 | Israel | 1 | |
| #6 | Republic of Korea | 1 | |
| #7 | New Zealand | 1 | |
| #8 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Medical technology | |
| #4 | Foods and drinks | |
| #5 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Climate change adaptation technologies | |
| #5 | Enzymes | |
| #6 | Electrotherapy |
| # | Name | Total Patents |
|---|---|---|
| #1 | Buckley James Thomas | 12 |
| #2 | Nickel John Curtis | 3 |
| #3 | Merchant Fahar | 2 |
| #4 | Thomas Buckley James | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2010069060A1 | Method for treating prostatitis utilizing modified pore-forming protein proaerolysin | |
| WO2010031185A1 | Treating cancer stem cells using targeted cargo proteins | |
| WO2007140618A1 | Modified protein toxins targeting cytokine -receptor bearing cells and use thereof for treating disease | |
| CA2630559A1 | Modified pore-forming protein toxins and use thereof | |
| KR20080042067A | Method of treating or preventing benign prostatic hyperplasia using modified pore-forming proteins |